Target intelligence / Profile preview

null

Target
null
Molecular classification
Other (Cellular checkpoint mechanism, not a receptor, enzyme, transporter, etc.)
01

Overview

Cell cycle arrest at G2/M is a regulatory checkpoint that halts the cell cycle prior to mitosis, allowing cells time to repair DNA damage or incomplete replication before chromosome segregation[1][2][4]. The checkpoint is controlled by a network of kinases and phosphatases (ATM, ATR, Chk1, Chk2, p53, Cdc25, Wee1, etc.), acting primarily on the cyclin B1/CDK1 complex[1][2][3][4]. Dysregulation leads to genomic instability, unchecked cell division, and cancer. Some anticancer agents and DNA damaging drugs exploit this checkpoint to induce apoptosis in rapidly dividing cancer cells. However, the term "cell cycle arrest at G2/M" refers to a process and not to a distinct target molecule or receptor.

Other names
G2/M arrestG2-M DNA damage checkpointG2 phase cell cycle arrest
02

Mechanism of action

Induction of DNA damage to trigger checkpoint activation and halt progress at G2/M[1][3] - Inhibition or activation of checkpoint kinases (ATM, ATR, Chk1, Chk2) - Inhibition of Cdc25 phosphatases (block activation of CDK1/cyclin B1 complex, preventing entry to mitosis) - Disruption of CDK1/cyclin B1 complex and its regulators (Wee1, p21, p53)

03

Biological functions

Cell cycle controlDNA damage responseCell proliferationApoptosis (following failed arrest/repair)Genomic stability
04

Disease associations

Cancer (disruption of G2/M control is a hallmark of many cancers[1][4])Infection (various viruses subvert G2/M checkpoint to benefit their replication[2])
05

Safety considerations

Bone marrow suppression and cytopenias (from excessive arrest in proliferating cells)Secondary malignancy (if DNA damage repair fails and mutagenesis occurs)Gastrointestinal toxicityNon-specific cell death/apoptosis in normal tissues with high proliferation rates[3][4]
06

Interacting drugs

Checkpoint kinases (Chk1, Chk2 inhibitors)

4 more in the full profile.

07

Biomarkers

Phosphorylated Chk1 and Chk2p53 expression and activation statep21 expressionγH2AX (marker of DNA damage)Phosphorylated Cdc25Cyclin B1 accumulation

Beyond the preview

Go deeper on null.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on null.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call